Chiesi USA, Inc., headquartered in Cary, N.C., is a specialty pharmaceutical company focused on commercialization of products for the hospital, rare disease and target office-based specialties.
Our employees take an entrepreneurial approach to meet the evolving needs of our customers. As a Public Benefit Corporation, Chiesi USA is committed to operating as a good corporate citizen; positively impacting communities in which we live and serve.
Headquartered in Cary NC, we employ approximately 300 employees in the United States. Previously known as Cornerstone Therapeutics, the company was acquired by the Chiesi Group in 2014. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A.
Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with more than 80 years of experience in the pharmaceutical industry. The Group employs more than 5,300 people in 27 affiliates worldwide, selling products in more than 80 countries. Chiesi is recognized as a top 50 company in terms of revenue and R&D.
Careers at Chiesi USA Inc: Email: Chiesiusa.jobs@chiesi.com
Business Development: Email: us.busdev@chiesi.com
All other inquiries: Email: us.contact@chiesi.com
Our employees take an entrepreneurial approach to meet the evolving needs of our customers. As a Public Benefit Corporation, Chiesi USA is committed to operating as a good corporate citizen; positively impacting communities in which we live and serve.
Headquartered in Cary NC, we employ approximately 300 employees in the United States. Previously known as Cornerstone Therapeutics, the company was acquired by the Chiesi Group in 2014. Chiesi USA, Inc. is a wholly-owned subsidiary of Chiesi Farmaceutici S.p.A.
Headquartered in Parma, Italy, Chiesi Farmaceutici is an international research-focused group with more than 80 years of experience in the pharmaceutical industry. The Group employs more than 5,300 people in 27 affiliates worldwide, selling products in more than 80 countries. Chiesi is recognized as a top 50 company in terms of revenue and R&D.
Careers at Chiesi USA Inc: Email: Chiesiusa.jobs@chiesi.com
Business Development: Email: us.busdev@chiesi.com
All other inquiries: Email: us.contact@chiesi.com
Location: United States, North Carolina, Cary
Employees: 1001-5000
Founded date: 1935
Investors 1
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
Mentions in press and media 31
| Date | Title | Description |
| 16.05.2024 | Mayor Michelle Wu and Mayor of Rome Roberto Gualtieri sign agreement to codify shared commitment to bolstering economic, climate, educational ties | Yesterday while at a meeting at Rome City Hall, Boston Mayor Michelle Wu and Rome Mayor Roberto Gualtieri signed a Declaration of Intent to establish a formal cultural and economic partnership between the cities of Boston and Rome. Recogniz... |
| 11.01.2023 | JPM23: Chiesi gets jump-start on JPM buzz with $1.48B Amryt buyout | - |
| 02.12.2022 | Chiesi USA Sponsors ASHP Advantage Initiative to Support Pharmacy Technician Recruitment and Retention | As a Certified B Corporation™, Chiesi deepens ASHP partnership to fund educational efforts designed to address the pharmacy technician shortage and support pharmaceutical professionals. /EIN News/ -- CARY, N.C., Dec. 02, 2022 (GLOBE NEWSWIR... |
| 29.11.2022 | Chiesi USA Announces Publication of Health Economics Analysis of Selective Early Rescue Surfactant Administration vs. Standard Surfactant Administration for Premature Infants with Respiratory Distress... | This cost-consequence analysis suggests selective early rescue surfactant administration strategies are associated with a lower healthcare burden in premature infants with RDS. /EIN News/ -- CARY, N.C., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Chi... |
| 17.10.2022 | Chiesi USA Chosen as One of Fortune’s 25 Best Small and Medium Workplaces in Biotechnology and Pharmaceuticals | Chiesi USA recognized for its dedication to ensuring that employee voices are heard and valued CARY, N.C., Oct. 17, 2022 (GLOBE NEWSWIRE) -- Chiesi USA, Inc. (key-A-zee), the U.S. affiliate of Chiesi Farmaceutici S.p.A., an international re... |
| 03.10.2022 | Chiesi USA Partners with Durham Bulls to Donate $15,000 to Three Triangle Nonprofits | CARY, N.C., Oct. 03, 2022 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), a Cary-based specialty pharmaceutical company, felt like part of the team as the company concluded its presenting strikeout partnership with the Durham Bulls minor league... |
| 22.09.2022 | Chiesi is Recertified as a B Corp and Sets New Tougher Objectives for Action by 2025 | The Group has increased its B Impact score by 16.3 points, with 103.8 out of 200 compared to its first certification in 2019The recertification process by B Lab identifies further focus for action and continuous improvement. CARY, N.C., Sep... |
| 06.09.2022 | Chiesi USA Reports Progress in ASHP Foundation’s Pharmacy Leadership Scholars Program | Chiesi USA sponsored the innovative ASHP Foundation Pharmacy Leadership Scholars program, awarding $50,000 in grants to five early-stage pharmacist researchers CARY, N.C., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S.... |
| 25.07.2022 | Chiesi Group joins White House pledge to decarbonize healthcare sector | Chiesi Group signed the HHS Health Care Sector Climate Pledge to achieve even greater progress on climate resilienceThe White House cited Chiesi’s leadership in exceeding the pledge by tackling emissions from fluorinated gases used in commo... |
| 14.07.2022 | Chiesi tracks actions taken for a healthier, more sustainable future | Chiesi’s Annual and Sustainability Report 2021 is released today;Progress toward business, environmental and social targets is strong;Company is joining forces with all stakeholders to advance sustainable healthcare. CARY, N.C., July 14, 20... |
Show more